A double-masked, placebo-controlled study with open-label period to evaluate the efficacy and safety of inebilizumab in adult subjects with neuromyelitis optica spectrum disorders–top line efficacy and safety results - Cree, B; Bennett, J; Kim, H J (Neurology, 2019)
(15 Suppl):